Oliceridine

CHEMBL2443262 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

386.6 g/mol

LogP

3.5

Phase

4

A G-protein-biased opioid for hospital acute pain management with potentially fewer respiratory side effects.

Molecular Weight

386.6000 g/mol

LogP

3.50

TPSA

71.60 Å²

Lipinski RO5

Pass

Therapeutic Areas

Chronic Pain Pain Management

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1

InChI

InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/t21-/m1/s1

Molecular Formula

C22H30N2O2S

HBD / HBA

1 / 5

Rotatable Bonds

7

Heavy Atoms

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A G-protein-biased opioid for hospital acute pain management with potentially fewer respiratory side effects.

Yes, Oliceridine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2443262. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 66553195. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Looking for patient-friendly information?

Oliceridine on PillFYI

Structure

Quick Data

Formula: C22H30N2O2S
Synonyms: 1

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.